Allena Pharmaceuticals Inc

NASDAQ:ALNA  
1.27
-0.03 (-2.31%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Allena Pharmaceuticals Inc Stock, NASDAQ:ALNA

One Newton Executive Park, Suite 202, Newton, Massachusetts 02462
United States of America
Phone: +1.617.467.4577
Number of Employees: 41

Description

Allena Pharmaceuticals, Inc. engages in the development, discovery and commercialization of oral enzyme therapeutics to treat patients with kidney disorders. Its product pipeline includes reloxaliase, an oral enzyme therapeutic for the treatment of enteric hyperoxaluria in adults and ALLN-346, which is used for patients with hyperuricemia and moderate to severe chronic kidney disease. The company was founded by Robert Gallotto and Alexey L. Margolin on June 24, 2011 and is headquartered in Newton, MA.